ENTITY

BTG PLC (BTG LN)

31
Analysis
Health Care • United Kingdom
BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.
more
•16 Sep 2025 21:39•Broker

Krungthai XSpring Zoom Eng. September 16, 2025

Prime Minister Anutin Charnvirakul confirmed that the Cabinet lineup is now finalized and undergoing qualification checks, with submission for...

Logo
264 Views
Share
•09 Sep 2025 20:26•Broker

Krungthai XSpring Zoom Eng. September 9, 2025

The SET Index is expected to trade with an upward bias today, with the support at 1,260/1,250 and the resistance at 1,276/1,291.

Logo
241 Views
Share
•30 Aug 2025 03:24•Broker

Krungthai XSpring Zoom Eng. August 29, 2025

The SET Index is expected to fluctuate today, with the support levels at 1,250/1,235 points and the resistance levels at 1,268/1,284 points.

Logo
400 Views
Share
•25 Aug 2025 20:57•Broker

Krungthai XSpring Zoom Eng. August 25, 2025

The SET Index is expected to continue rising today, with the support at 1,250/1,231 points and the resistance at 1,260/1,274 points.

Logo
276 Views
Share
bullish•BTG PLC
•22 Nov 2018 23:52•Issuer-paid

BTG - The BTG acquisition: Small fly, big ointment

Following our note on BTG’s interim results, the proposed £3.3bn all-cash acquisition by Boston Scientific was announced. Further, on 21 November,...

Share
x